Exactech Goes Private in $625M Deal With TPG Capital Post author:Sam Post published:October 22, 2017 Post category:BioPharma TPG Capital has acquired all the outstanding shares of Exactech common stock for $42 per share. Source: BioSpace You Might Also Like New York's Akari Puts CEO on Administrative Leave May 11, 2017 Endo International Slashes 875 Jobs and Will Shutter Alabama Facilities July 20, 2017 Mitsubishi Tanabe Coughs Up $1.1 Billion Cash for This Parkinson's Biotech July 23, 2017